Clinical research has evolved from traditional in-person trials (1.0) to virtual and hybrid trials (2.0), enabling patients to participate remotely through electronic forms and wearables, significantly improving data quality and patient compliance. This transition eliminates geographical limitations, allows convenient scheduling, and enhances the collection of diverse data points from multiple sources. Real-world examples demonstrate that technology in clinical trials can nearly double diagnosis rates for conditions like atrial fibrillation.